HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neuroimaging in acute posterior cerebral artery infarction.

AbstractBACKGROUND:
The role of neuroimaging in acute posterior cerebral artery (PCA) territory infarction is less well appreciated compared with the anterior cerebral circulation because PCA infarction occurs less frequently and more often is associated with limited neurologic deficit not qualifying for thrombolytic therapy. On occasion, however, hemiparesis and/or visual field defect accompanies PCA infarction that would warrant thrombolytic therapy.
REVIEW SUMMARY:
As neuroimaging plays a central role in the diagnosis and treatment of acute stroke in the thrombolytic era, a series of case studies is presented to illustrate the role of computed tomography and magnetic resonance imaging in the setting of acute PCA infarction.
CONCLUSION:
Familiarity with the neuroimaging features of acute PCA infarction can facilitate management in those select patients that qualify for thrombolytic therapy.
AuthorsPasquale F Finelli
JournalThe neurologist (Neurologist) Vol. 14 Issue 3 Pg. 170-80 (May 2008) ISSN: 1074-7931 [Print] United States
PMID18469674 (Publication Type: Case Reports, Journal Article, Review)
Chemical References
  • Fibrinolytic Agents
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Brain (blood supply, diagnostic imaging, pathology)
  • Cerebral Angiography (methods, standards)
  • Cerebrovascular Circulation (physiology)
  • Circle of Willis (abnormalities)
  • Disability Evaluation
  • Female
  • Fibrinolytic Agents (standards)
  • Humans
  • Infarction, Posterior Cerebral Artery (diagnostic imaging, pathology, physiopathology)
  • Magnetic Resonance Imaging (methods, standards)
  • Male
  • Middle Aged
  • Posterior Cerebral Artery (anatomy & histology, diagnostic imaging, pathology)
  • Predictive Value of Tests

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: